)
Seco (IOT) investor relations material
Seco Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
9M26 net sales rose 8.12% YoY to €158.325m; 3Q26 sales reached €59.6m, up 24% YoY, with adjusted EBITDA of €14.7m, up 38%.
9M26 adjusted EBITDA was €33.195m, up 7.72%, with a 21.0% margin; 3Q26 margin rose to 24.7% as operating leverage improved.
Clea 2.0, silicon and channel partnerships, and acquisitions advanced the strategy to expand Edge AI capabilities and build an APAC platform.
Financial highlights
9M26 net sales were €158.325m versus €146.4m; gross profit was €84.9m at a 53.6% margin, versus €78.8m and 53.8% in 9M25.
9M26 adjusted EBITDA was €33.195m, up 7.72%; reported EBITDA was €29.389m, up 15.60%, and adjusted EBIT was €18.3m, up 6.2%.
Adjusted net income rose 11.9% to €12.7m; reported net income was €7.510m versus €4.637m, with €4.068m attributable to shareholders versus €1.882m.
3Q26 sales were €59.6m, up 24% YoY and 19% QoQ; adjusted EBITDA rose 38% YoY and 56% QoQ, while EBIT and net income grew 102% and 166% YoY.
3Q26 gross margin was 56.0%, versus 52.3% in 2Q26 and 52.6% in 1Q26; adjusted EBITDA reached €14.7m at a 24.7% margin.
Outlook and guidance
Official FY2027 revenue guidance was planned for December 2026; the €270m figure discussed was consensus, not guidance, and excluded Qiyang.
Positive order intake, a robust design-win pipeline, 42% backlog growth and 1.2x book-to-bill through October YTD supported visibility; Neura orders were not yet in reported backlog.
Q4 was expected to be broadly similar to Q3, subject to component availability; management cited orders, backlog and incoming components as support.
Gradual product price increases were planned for 2027 to help offset rising memory costs while limiting customer impact.
- Q3 2026 revenue is guided at a record €60M, reflecting strong Edge AI momentum.IOT
Q2 2026 TU - Stable revenues and strong order intake, but profit pressured by costs and supply chain issues.IOT
Q2 2026 - Net sales up 2.91% to €48.5m, Clea recurring revenue up 20%, and strong Q2 outlook.IOT
Q1 2026 - Sales up 5%, margin at 53.8%, EBITDA up 50.8%, and €200M+ revenue guidance reaffirmed.IOT
Q3 2025 - H1 2025 sales up 3.2%, gross margin 53.4%, EBITDA margin 20.5%, FY25 revenue to exceed €200m.IOT
Q2 2025 - Net sales dropped 14% but gross margin and Clea software rose; partnerships fuel future growth.IOT
Q3 2024 - Sales dropped 15% but gross margin rose to 52.7% as software grew 17%; 2025 rebound targeted.IOT
Q2 2024 - Q1 2025 sales flat YoY, margins strong, Clea recurring revenue up, and order pipeline robust.IOT
Q1 2025 - Sales fell 12.5–13%, but margins held firm and 2025 recovery is expected.IOT
Q4 2024
)
)
)
)
)
)
)
)